Q and A .. When will the Coronavirus vaccine be ready?

At least 53 vaccinations undergo one vaccine COVID-19 Clinical trials around the world, including 4 of the most promising companies, have reached the final third stage, while their safety and effectiveness are being evaluated, using tens of thousands of volunteers.

But the most famous question remains, when will the vaccine be ready?

To find out more, two principal investigators speak on the trials: Dr. Susan Little, a professor of medicine, and Dr. Stephen A. Spector, distinguished professor of pediatrics, both at the University of San Diego School of Medicine, according to a website report. the coronavirus”

Q: Is it realistic to hope that one or more vaccines will be approved before the end of the year?

This is possible, but I am important to ensure that any licensed vaccine is safe and effective, and we must bear in mind that new vaccines usually require a decade or more to develop, while scientists are working on a vaccine. COVID-19 Less than a year ago, and here we are in multiple Phase III trials, so even though we all want to have a vaccine today, it is vitally important to make sure that the scientists conducting the studies and the public that will receive the vaccine trust the process.

Q: Why is it important to develop the COVID-19 vaccine?

Anyone can become infected with Coronavirus, and a large percentage of people remain infected with it -CoV-2 Asymptomatic, the overall likelihood of asymptomatic infection is currently thought to be between 15 and 20%, although this rate decreases with age.

Societal transmission of Coronavirus, both from asymptomatic and asymptomatic people, remains one of the major public health challenges of current measures to control mitigation, such as face masks and social distancing.

There are a number of factors that increase the risk of developing serious diseases. The people most at risk of infection are men and the elderly, with an increased risk of serious diseases for those over the age of 65. In addition, some basic conditions exacerbate the risks: obesity, cancer, chronic kidney or lung disease, which is a serious heart condition or diabetes, for example. Example.

s. Are there certain groups of people that should register for an experiment?

Since people of color are at particular risk of developing a disease COVID-19 The dangerous, we are particularly interested in registering people from these communities in vaccine trials.

Many residents of color have higher rates of hospitalization with COVID-19 Some have higher death rates, and it is critical that all three trials enroll ethnically diverse populations to address questions of vaccine efficacy in groups that appear to have more severe clinical outcomes than COVID-19.

– .